Eventide Asset Management, LLC 13D and 13G filings for Nektar Therapeutics:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 12:08 pm Sale |
2024-12-31 | 13G | Nektar Therapeutics NKTR |
Eventide Asset Management, LLC | 6,650,000 3.610% |
-2,750,000 (-29.26%) |
Filing |
| 2024-11-14 12:17 pm Purchase |
2024-09-30 | 13G | Nektar Therapeutics NKTR |
Eventide Asset Management, LLC | 9,400,000 5.110% |
9,400,000 (New Position) |
Filing |